Accuray | ARAY - Cash And Equivalent

Stock Price
0.54
Daily Change
-0.02 -3.08%
Monthly
-33.90%
Yearly
-74.63%
Q1 Forecast
0.52

Accuray reported $63.34M in Cash and Equivalent for its fiscal quarter ending in September of 2025.





Cash And Equivalent Change Date
Abbott USD 8.52B 1.01B Dec/2025
Accuray USD 63.34M 5.93M Sep/2025
AngioDynamics USD 44.76M 9.33M Feb/2025
Artivion USD 73.43M 19.95M Sep/2025
AtriCure USD 167.43M 19.56M Dec/2025
Boston Scientific USD 1.96B 690M Dec/2025
Edwards Lifesciences USD 2.69B 587.2M Sep/2025
Hologic USD 2.17B 208.5M Dec/2025
Inogen USD 106.48M 2.79M Sep/2025
Mesa Laboratories USD 28.98M 8.55M Dec/2025
Orthofix International USD 62.86M 2.75M Sep/2025
Surmodics USD 36.11M 11.81M Sep/2024
Tandem Diabetes Care USD 90.63M 1.31M Dec/2025
Trinity Biotech USD 1.34M 3.83M Sep/2025